Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Insulin Pump Bill May Inject New Life Into Third-Party Coverage

This article was originally published in The Gray Sheet

Executive Summary

Pending Senate legislation that would provide Medicare coverage for external insulin pumps could offer manufacturers leverage over third-party insurers.

You may also be interested in...

HCFA Insulin Pump Coverage Decision Estimates Annual Cost At $3,329

The annual cost of insulin therapy administered through a subcutaneous infusion pump is $3,329, the Health Care Financing Administration estimates in a Medicare national coverage decision for the devices in Type I diabetes announced Sept. 24. An effective date will be specified in an upcoming instruction to carriers.

India Rare Disease Policy Proposes Crowdfunding But Patients Feel Let Down

Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts